OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS
Bassam M. Ayoub, Haidy E. Michel, Shereen Mowaka, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 889-889
Open Access | Times Cited: 16
Bassam M. Ayoub, Haidy E. Michel, Shereen Mowaka, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 889-889
Open Access | Times Cited: 16
Showing 16 citing articles:
Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis‐related NLRP3 pathway
Shuang Song, Ruoyi Guo, Arshad Mehmood, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 3, pp. 422-434
Open Access | Times Cited: 66
Shuang Song, Ruoyi Guo, Arshad Mehmood, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 3, pp. 422-434
Open Access | Times Cited: 66
Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
Karel H. van der Pol, Mohamad Aljofan, Olivier Blin, et al.
Applied Health Economics and Health Policy (2023) Vol. 21, Iss. 6, pp. 831-840
Open Access | Times Cited: 24
Karel H. van der Pol, Mohamad Aljofan, Olivier Blin, et al.
Applied Health Economics and Health Policy (2023) Vol. 21, Iss. 6, pp. 831-840
Open Access | Times Cited: 24
Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM)
Dong-Wei Shao, Zhao Lijie, Jinfeng Sun
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116464-116464
Closed Access | Times Cited: 7
Dong-Wei Shao, Zhao Lijie, Jinfeng Sun
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116464-116464
Closed Access | Times Cited: 7
Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review
Thahesh Tharmaraja, Jamie Sin Ying Ho, Ching‐Hui Sia, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232210869-204062232210869
Open Access | Times Cited: 24
Thahesh Tharmaraja, Jamie Sin Ying Ho, Ching‐Hui Sia, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232210869-204062232210869
Open Access | Times Cited: 24
Synthesis, X-ray crystallography, computational investigation on quinoxaline derivatives as potent against adenosine receptor A2AAR
Shaaban K. Mohamed, Sabir Ali Siddique, S. Karthikeyan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access | Times Cited: 4
Shaaban K. Mohamed, Sabir Ali Siddique, S. Karthikeyan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access | Times Cited: 4
Omarigliptin/rosinidin combination ameliorates cyclophosphamide-induced lung toxicity in rats: The interaction between glucagon-like peptide-1, TXNIP/NLRP3 inflammasome signaling, and PI3K/Akt/FoxO1 axis
Maaly A. Abd Elmaaboud, Ahmed M Kabel, Hany M Borg, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117026-117026
Open Access | Times Cited: 3
Maaly A. Abd Elmaaboud, Ahmed M Kabel, Hany M Borg, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117026-117026
Open Access | Times Cited: 3
Dapagliflozin Ameliorate Type-2 Diabetes Associated Neuropathy via Regulation of IGF-1R Signaling
Prabhsimran Kaur, Tashvinder Singh, Laxmipriya Jena, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Prabhsimran Kaur, Tashvinder Singh, Laxmipriya Jena, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Omarigliptin/galangin combination mitigates lipopolysaccharide-induced neuroinflammation in rats: Involvement of glucagon-like peptide-1, toll-like receptor-4, apoptosis and Akt/GSK-3β signaling
Ahmed M. Kabel, Hany H. Arab, Aliaa Atef, et al.
Life Sciences (2022) Vol. 295, pp. 120396-120396
Closed Access | Times Cited: 15
Ahmed M. Kabel, Hany H. Arab, Aliaa Atef, et al.
Life Sciences (2022) Vol. 295, pp. 120396-120396
Closed Access | Times Cited: 15
Omarigliptin inhibits brain cell ferroptosis after intracerebral hemorrhage
Yan Zhang, Yang Liu, V. Wee Yong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Yan Zhang, Yang Liu, V. Wee Yong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Linagliptin counteracts rotenone’s toxicity in non-diabetic rat model of Parkinson’s disease: Insights into the neuroprotective roles of DJ-1, SIRT-1/Nrf-2 and implications of HIF1-α
Rania Z ElGamal, Mariane G. Tadros, Esther T. Menze
European Journal of Pharmacology (2023) Vol. 941, pp. 175498-175498
Closed Access | Times Cited: 6
Rania Z ElGamal, Mariane G. Tadros, Esther T. Menze
European Journal of Pharmacology (2023) Vol. 941, pp. 175498-175498
Closed Access | Times Cited: 6
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
Ingrid Langer, Dorota Latek
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 10
Ingrid Langer, Dorota Latek
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 10
Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection
Maja Jazvinšćak Jembrek
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1033-1033
Open Access | Times Cited: 1
Maja Jazvinšćak Jembrek
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1033-1033
Open Access | Times Cited: 1
Impacts of trelagliptin and remogliflozin alone and in combination with Alpha Lipoic Acid on cardiac function in streptozotocin-induced diabetes mellitus in rats
Mohammed Abdullah Ali, Ansam N. Al-Hassani, Badraldin Kareem Hamad
Cellular and Molecular Biology (2023) Vol. 69, Iss. 9, pp. 106-112
Open Access | Times Cited: 3
Mohammed Abdullah Ali, Ansam N. Al-Hassani, Badraldin Kareem Hamad
Cellular and Molecular Biology (2023) Vol. 69, Iss. 9, pp. 106-112
Open Access | Times Cited: 3
Omarigliptin attenuates rotenone-induced Parkinson's disease in rats: Possible role of oxidative stress, endoplasmic reticulum stress and immune modulation
Haidy E. Michel, Mariam M. Tadros, Moataz S. Hendy, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113015-113015
Closed Access | Times Cited: 5
Haidy E. Michel, Mariam M. Tadros, Moataz S. Hendy, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113015-113015
Closed Access | Times Cited: 5
The potential off‐target neuroprotective effect of sister gliflozins suggests their repurposing despite not crossing the blood–brain barrier: From bioanalytical assay in rats into theory genesis
Moataz S. Hendy, Shereen Mowaka, Ehab F. Elkady, et al.
Journal of Separation Science (2023) Vol. 46, Iss. 6
Closed Access | Times Cited: 2
Moataz S. Hendy, Shereen Mowaka, Ehab F. Elkady, et al.
Journal of Separation Science (2023) Vol. 46, Iss. 6
Closed Access | Times Cited: 2
BEYOND BLOOD SUGAR CONTROL: A COMPREHENSIVE REVIEW OF DPP-4 INHIBITORS AND THEIR EXPANDING LANDSCAPE
Parul Srivastava, Pranay Wal, Versha Chaturvedi, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2022)
Open Access
Parul Srivastava, Pranay Wal, Versha Chaturvedi, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2022)
Open Access
